Codex DNA, Inc. (DNAY) Cash Flow Annual - Discounting Cash Flows
DNAY
Codex DNA, Inc.
DNAY (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
Report Filing: 2024-11-07 2023-03-22 2022-03-23 2020-12-31
Net Income/Starting Line -16.75 -48.47 -38.96 -18.01
Cash From Operating Activities -4.38 -38.72 -36.7 -15.38
Depreciation and Amortization 1.01 1.67 0.908 1.46
Deferred Income Tax 0 0 0 0
Stock Based Compensation 1.04 3.73 1.09 0.043
Other Non-Cash Items 8.49 5.21 3.3 1.15
Changes in Working Capital 1.82 -0.855 -3.04 -0.02
Accounts Receivable 3.93 -2.19 -0.735 -0.774
Inventory 1.24 0.168 -1.46 0.111
Accounts Payable 0.713 1.16 4.39 0.142
Deferred Revenue -1.82 0.855 -5.23 0.501
Other Working Capital -2.24 -0.855 0 0
Cash From Investing Activities 13.7 -18.01 -15.04 -0.204
Investments in Property Plant and Equipment -0.168 -4.47 -1.85 -0.204
Payments for Acquisitions 0 0 0 0
Purchases of Securities 2.57 -77.43 0 0
Sales and Maturities of Investments 9.85 64.44 0 0
Other Investing Activities 1.44 -0.556 -13.19 0
Cash From Financing Activities -0.184 4.51 121.1 -0.096
Debt Repayment 0 0 0 0
Common Stock Issued 0.012 0.098 112.5 0
Common Stock Repurchased 0 0 0 0
Dividends Paid -1.8 0 0 0
Other Financing Activities 1.63 4.51 121.1 -0.096
Effect of Forex Changes on Cash -0.002 0 0 0
Net Change in Cash -26.77 -52.21 69.34 -15.68
Cash at Beginning of Period 30.59 82.81 13.46 29.14
Cash at End of Period 3.82 30.59 82.81 13.46
Free Cash Flow -4.54 -43.18 -38.55 -15.59
Operating Cash Flow -4.38 -38.72 -36.7 -15.38
Capital Expenditure -0.168 -4.47 -1.85 -0.204
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us